Halstead SB, Jacobson J, 2003. Japanese encephalitis. Adv Virus Res 61: 103–138.
Halstead SB, Tsai TF, 2004. Japanese encephalitis vaccines. Plotkin SA, Orenstein WA, eds. Vaccines. Fourth edition. Philadelphia: Saunders, 919–958.
Solomon T, 2004. Flavivirus encephalitis. N Engl J Med 351: 370–378.
Report of the Bi-Regional Meeting on Japanese Encephalitis (WHO SEA/WPR AND /PATH's JE Project), 2005. Bangkok, Thailand, March 30–April 1, 2005.
World Health Organization, 1996. The World Health Report, 1996: Fighting Disease, Fostering Development. Geneva: World Health Organization.
World Health Organization, 2006. Japanese encephalitis vaccines. Wkly Epidemiol Rec 81: 331–340.
Fischer M, Campbell G, 2007. Japanese Encephalitis. Health Information for International Travel, 2008. Arguin PM, Kozarsky PE, Reed C, eds. Atlanta: US Department of Health and Human Services, Public Health Services, 190–201.
Parida M, Dash PK, Tripathi NK, Ambuj, Sannarangaiah S, Saxena P, Agarwal S, Sahni AK, Singh SP, Rathi AK, Bhargava R, Abhyankar A, Verma SK, Rao PV, Sekhar K, 2006. Japanese encephalitis outbreak, India, 2005. Emerg Infect Dis 12: 1427–1430.
Partridge J, Ghimire P, Sedai T, Bista MB, Banerjee M, 2007. Endemic Japanese encephalitis in the Kathmandu Valley, Nepal. Am J Trop Med Hyg 77: 1146–1149.
Hennessy S, Liu Z, Tsai TF, Strom BL, Wan CM, Liu HL, Wu TX, Yu HJ, Liu QM, Karabatsos N, Bilker WB, Halstead SB, 1996. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 347: 1583–1586.
Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K, 1988. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608–614.
Tsai TF, 2000. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 18 (Suppl 2): 1–25.
Myint L, Hlaing W, Thu HM, Than SM, Aye KT, Ha T, Moe K & Thein S 2000. Investigation of Japanese encephalitis virus infection in Bogalay Township, Myanmar in 1999. Trop Med 42: 47–52.
Kaur R, Agarwal CS, Das D, 2002. An investigation into the JE epidemic of 2000 in Upper Assam: a perspective study. J Commun Dis 34: 135–145.
Liu W, Clemens JD, Kari K, Xu ZY, 2008. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia. Vaccine 26: 4456–4460.
Raina VK, Khaparde SD, 2009. India: JE immunization in Routine Immunization-Opportunities and Challenges. Ministry of Health and Family Welfare. Government of India. Presented at Fourth Biregional Meeting on the Control of Japanese Encephalitis. June 8–9, 2009, Bangkok, Thailand.
Khan AM, Khan AQ, Dobrzynski L, Joshi GP, Myat A, 1981. A Japanese encephalitis focus in Bangladesh. J Trop Med Hyg 84: 41–44.
Slidex Meningite-Kit 5. REF 58 803. Marcy l’Etoile, France: bioMerieux. Available at: http://www.biomerieux.com.
Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 1823–1826.
Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Brandt WE, 1989. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70: 37–43.
STATA Data Analysis and Statistical Software, Version 10. College Station, TX: Stata Corporation. Available at: http://www.stata.com.
Mackenzie JS, Gubler DJ, Petersen LR, 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10: S98–S109.
Marfin AA, Eidex RS, Kozarsky PE, Cetron MS, 2005. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am 19: 151–168 ix.
Sunish IP, Reuben R, 2001. Factors influencing the abundance of Japanese encephalitis vectors in ricefields in India. I. Abiotic. Med Vet Entomol 15: 381–392.
Renshaw M, Elias M, Maheswary NP, Hassan MM, Silver JB, Birley MH, 1996. A survey of larval and adult mosquitoes on the flood plains of Bangladesh, in relation to flood-control activities. Ann Trop Med Parasitol 90: 621–634.
World Health Organiztion, 1998. Japanese encephalitis vaccines. Wkly Epidemiol Rec 73: 337–344.
Wierzba TF, Ghimire P, Malla S, Banerjee MK, Shrestha S, Khanal B, Sedai TR, Gibbons RV, 2008. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy. Am J Trop Med Hyg 78: 1002–1006.
Kar NJ, Bora D, Sharma RC, Bhattacharjee J, Datta KK, Sharma RS, 1992. Epidemiological profile of Japanese encephalitis in Gorakhpur district, Uttar Pradesh, 1982–1988. J Commun Dis 24: 145–149.
Solomon T, Thao TT, Lewthwaite P, Ooi MH, Kneen R, Dung NM, White N, 2008. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ 86: 178–186.
Kaur AR, Agarwal CS, Das D, 2002. An investigation into the JE epidemic of 2000 in Upper Assam: a perspective study. J Commun Dis 34: 135–145.
Kari K, Liu W, Gautama K, Mammen MP Jr, Clemens JD, Nisalak A, Subrata K, Kim HK, Xu ZY, 2006. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med 4: 8.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 693 | 625 | 35 |
Full Text Views | 520 | 21 | 0 |
PDF Downloads | 287 | 28 | 1 |
We investigated the epidemiology and etiology of encephalitis at four tertiary hospitals in Bangladesh during 2003–2005. Patients who met a clinical case definition for acute encephalitis and had cerebrospinal fluid (CSF) pleocytosis were eligible for enrollment; a standardized sampling pattern was used to enroll eligible patients. Recent Japanese encephalitis virus (JEV) infection was defined by presence of IgM antibodies against JEV in CSF or serum. Twenty (4%) of 492 cases had laboratory evidence of recent JEV infection; two died. All JE cases occurred during May–December, and cases were identified among all age groups. All cases resided in rural areas. Fifteen patients were re-assessed 4–6 weeks after hospitalization; 5 (33%) patients had physical disabilities and 7 (47%) reported cognitive difficulties. Infection with JEV is clearly an etiology of encephalitis in Bangladesh. Population-based studies to quantify burden of disease could assess options for targeted immunization programs.
Financial support: This study was supported by the Centers for Disease Control and Prevention.
Authors' addresses: M. Jahangir Hossain, Emily S. Gurley, and Robert F. Breiman, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh, E-mails: jhossain@icddrb.org, egurley@icddrb.org, and rbreiman@ke.cdc.gov. Susan Montgomery, Lyle Petersen, James Sejvar, Marc Fischer, Amanda Panella, and Ann M. Powers, Centers for Disease Control and Prevention, Atlanta, GA, E-mails: zqu6@cdc.gov, lxp2@cdc.gov, zea3@cdc.gov, mxf2@cdc.gov, ahf6@cdc.gov, and akp7@cdc.gov. Nazmun Nahar and A. K. M. Rafique Uddin, Dhaka Medical College Hospital, Dhaka, Bangladesh, E-mails: nahar@dab-bd.org and rudduin-bsm@yahoo.com. M. Ekhlasur Rahman, Mymensingh Medical College Hospital, Myemsingh, Bangladesh and MAG Osmani Medical College Hospital, Sylhet, Bangladesh, E-mail: pediatrics_03@yahoo.com. A. R. M. Saifuddin Ekram, Rajshahi Medical College Hospital, Rajshahi, Bangladesh, E-mail: armsekram@yahoo.com. Stephen P. Luby, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh and Centers for Disease Control and Prevention, Atlanta, GA, E-mail: sluby@icddrb.org.
Halstead SB, Jacobson J, 2003. Japanese encephalitis. Adv Virus Res 61: 103–138.
Halstead SB, Tsai TF, 2004. Japanese encephalitis vaccines. Plotkin SA, Orenstein WA, eds. Vaccines. Fourth edition. Philadelphia: Saunders, 919–958.
Solomon T, 2004. Flavivirus encephalitis. N Engl J Med 351: 370–378.
Report of the Bi-Regional Meeting on Japanese Encephalitis (WHO SEA/WPR AND /PATH's JE Project), 2005. Bangkok, Thailand, March 30–April 1, 2005.
World Health Organization, 1996. The World Health Report, 1996: Fighting Disease, Fostering Development. Geneva: World Health Organization.
World Health Organization, 2006. Japanese encephalitis vaccines. Wkly Epidemiol Rec 81: 331–340.
Fischer M, Campbell G, 2007. Japanese Encephalitis. Health Information for International Travel, 2008. Arguin PM, Kozarsky PE, Reed C, eds. Atlanta: US Department of Health and Human Services, Public Health Services, 190–201.
Parida M, Dash PK, Tripathi NK, Ambuj, Sannarangaiah S, Saxena P, Agarwal S, Sahni AK, Singh SP, Rathi AK, Bhargava R, Abhyankar A, Verma SK, Rao PV, Sekhar K, 2006. Japanese encephalitis outbreak, India, 2005. Emerg Infect Dis 12: 1427–1430.
Partridge J, Ghimire P, Sedai T, Bista MB, Banerjee M, 2007. Endemic Japanese encephalitis in the Kathmandu Valley, Nepal. Am J Trop Med Hyg 77: 1146–1149.
Hennessy S, Liu Z, Tsai TF, Strom BL, Wan CM, Liu HL, Wu TX, Yu HJ, Liu QM, Karabatsos N, Bilker WB, Halstead SB, 1996. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 347: 1583–1586.
Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, Kotchasenee S, Gingrich JB, Latendresse J, Fukai K, 1988. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 319: 608–614.
Tsai TF, 2000. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 18 (Suppl 2): 1–25.
Myint L, Hlaing W, Thu HM, Than SM, Aye KT, Ha T, Moe K & Thein S 2000. Investigation of Japanese encephalitis virus infection in Bogalay Township, Myanmar in 1999. Trop Med 42: 47–52.
Kaur R, Agarwal CS, Das D, 2002. An investigation into the JE epidemic of 2000 in Upper Assam: a perspective study. J Commun Dis 34: 135–145.
Liu W, Clemens JD, Kari K, Xu ZY, 2008. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia. Vaccine 26: 4456–4460.
Raina VK, Khaparde SD, 2009. India: JE immunization in Routine Immunization-Opportunities and Challenges. Ministry of Health and Family Welfare. Government of India. Presented at Fourth Biregional Meeting on the Control of Japanese Encephalitis. June 8–9, 2009, Bangkok, Thailand.
Khan AM, Khan AQ, Dobrzynski L, Joshi GP, Myat A, 1981. A Japanese encephalitis focus in Bangladesh. J Trop Med Hyg 84: 41–44.
Slidex Meningite-Kit 5. REF 58 803. Marcy l’Etoile, France: bioMerieux. Available at: http://www.biomerieux.com.
Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 1823–1826.
Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, Brandt WE, 1989. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 70: 37–43.
STATA Data Analysis and Statistical Software, Version 10. College Station, TX: Stata Corporation. Available at: http://www.stata.com.
Mackenzie JS, Gubler DJ, Petersen LR, 2004. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10: S98–S109.
Marfin AA, Eidex RS, Kozarsky PE, Cetron MS, 2005. Yellow fever and Japanese encephalitis vaccines: indications and complications. Infect Dis Clin North Am 19: 151–168 ix.
Sunish IP, Reuben R, 2001. Factors influencing the abundance of Japanese encephalitis vectors in ricefields in India. I. Abiotic. Med Vet Entomol 15: 381–392.
Renshaw M, Elias M, Maheswary NP, Hassan MM, Silver JB, Birley MH, 1996. A survey of larval and adult mosquitoes on the flood plains of Bangladesh, in relation to flood-control activities. Ann Trop Med Parasitol 90: 621–634.
World Health Organiztion, 1998. Japanese encephalitis vaccines. Wkly Epidemiol Rec 73: 337–344.
Wierzba TF, Ghimire P, Malla S, Banerjee MK, Shrestha S, Khanal B, Sedai TR, Gibbons RV, 2008. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy. Am J Trop Med Hyg 78: 1002–1006.
Kar NJ, Bora D, Sharma RC, Bhattacharjee J, Datta KK, Sharma RS, 1992. Epidemiological profile of Japanese encephalitis in Gorakhpur district, Uttar Pradesh, 1982–1988. J Commun Dis 24: 145–149.
Solomon T, Thao TT, Lewthwaite P, Ooi MH, Kneen R, Dung NM, White N, 2008. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ 86: 178–186.
Kaur AR, Agarwal CS, Das D, 2002. An investigation into the JE epidemic of 2000 in Upper Assam: a perspective study. J Commun Dis 34: 135–145.
Kari K, Liu W, Gautama K, Mammen MP Jr, Clemens JD, Nisalak A, Subrata K, Kim HK, Xu ZY, 2006. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med 4: 8.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 693 | 625 | 35 |
Full Text Views | 520 | 21 | 0 |
PDF Downloads | 287 | 28 | 1 |